The 6th Gene Therapy Analytical Development & CMC Summit will unite 250+ analytical development, CMC, QC, and process development experts to showcase innovative analytical and process development methods, assess their readiness, and ultimately guarantee safety, quality, efficacy, and consistency of gene therapies to regulators.

Join ASGCT and the Muscular Dystrophy Association in downtown Chicago for an unparalleled opportunity to delve into the latest advancements in research on gene and cell therapies for muscular dystrophy.

This Scientific Exchange with the FDA seeks to make progress on therapeutic development for rare conditions that are scientifically feasible but commercially non-viable.

The Reagan-Udall Foundation for the FDA, in collaboration with the Food and Drug Administration (FDA), is hosting a public webinar as part of a series of webinars for FDA-issued guidance related to real-world evidence (RWE). This latest session in the webinar series will discuss the draft guidance: Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice.

This free, public event will explore key immunology-related topics that have implications across the class of AAV gene therapies, including immune responses, antibody testing, and redosing strategies.

Stay tuned for more details

With well over 5,000 attendees the Festival is now the [...]

The Advanced Therapies Congress is Europe’s largest commerical cell and [...]

Join peers to drive gene therapy innovation across translational, clinical, regulatory, and manufacturing tracks.

Meet the global CRISPR Medicine community at the second CRISPR MEDiCiNE conference.

Human Genetics and Genetical Disorders-2025 extend our immense pleasure and honor [...]

Stay tuned for more information on ASGCT's 2025 annual meeting. [...]

The Festival is designed principally for scientists and clinicians who are [...]

We cordially invite you to The Global Cell & Gene [...]